Form 4 for DBVT DBV Technologies S.A.

Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-22 · accession 0001209191-21-066788 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-11-24	2021-11-22	DBVT	Mohideen Pharis	Chief Medical Off	A - Grant	$0.00	+8,700	24.2K	+56%	$0
D	2021-11-24	2021-11-22	DBVT	Mohideen Pharis	Chief Medical Off	A - Grant	$0.00	+95.4K	95.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2021-11-22	A	A	8,700	$0.00	24,200	D	—	—	(F1) The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share. (F2) Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on November 22, 2022, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
2	Derivative	Employee Stock Option (right to buy)	2021-11-22	A	A	95,400	$0.00	95,400	D	$6.62 · — to 2031-11-22	95,400 Ordinary Shares	(F3) This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1278 to EURO 1.00 as of November 22, 2021. (F4) 25% of the shares subject to the option vest on November 22, 2022, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.